The distribution of saponins in vivo affects their synergy with chimeric toxins against tumours expressing human epidermal growth factor receptors in mice

British Journal of Pharmacology

Volumn 159, Issue 2, 2010, Pages 345-352

  Bachran, C ^a   Weng, A ^b   Bachran, D ^a   Riese, S B ^a   Schellmann, N ^a   Melzig, M F ^b   Fuchs, Hendrik ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cancer therapy; Chimeric toxin; Epidermal growth factor; Immunotoxin; Saponinum album; Saporin

Indexed keywords

CHIMERIC TOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; SAPONIN; TOXIN; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; FEMALE; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARYOPHYLLACEAE; CELL LINE; CELL LINE, TUMOR; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOTOXINS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RIBOSOME INACTIVATING PROTEINS, TYPE 1; SAPONINS; TISSUE DISTRIBUTION; TRITIUM;

EID: 75649088462     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00543.x     Document Type: Article

References (43)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 209.
2. Bachran C, Sutherland M, Heisler I, Hebestreit P, Melzig MF, Fuchs H (2006). The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure. Exp Biol Med (Maywood) 231 : 412 420.
3. Bachran C, Bachran S, Sutherland M, Bachran D, Fuchs H (2008a). Saponins in tumor therapy. Mini Rev Med Chem 8 : 575 584.
4. Bachran C, Heisler I, Bachran D, Dassler K, Ervens J, Melzig MF et al. (2008b). Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cells. Cancer Biol Ther 7 : 237 242.
5. Bachran C, Durkop H, Sutherland M, Bachran D, Muller C, Weng A et al. (2009). Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic way. J Immunother 32 : 713 725.
6. Baumann E, Stoya G, Volkner A, Richter W, Lemke C, Linss W (2000). Hemolysis of human erythrocytes with saponin affects the membrane structure. Acta Histochem 102 : 21 35.
7. Chinn PC, Leonard JE, Rosenberg J, Hanna N, Anderson DR (1999). Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma. Int J Oncol 15 : 1017 1025.
8. Chwalek M, Lalun N, Bobichon H, Ple K, Voutquenne-Nazabadioko L (2006). Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis induction. Biochim Biophys Acta 1760 : 1418 1427.
9. Frankel AE, Fleming DR, Hall PD, Powell BL, Black JH, Leftwich C et al. (2003). A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. Clin Cancer Res 9 : 3555 3561.
10. Fuchs H, Bachran C (2009). Targeted tumor therapies at a glance. Curr Drug Targets 10 : 89 93.
11. Fuchs H, Bachran C, Li T, Heisler I, Durkop H, Sutherland M (2007). A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice. J Control Release 117 : 342 350.
12. Fuchs H, Bachran D, Panjideh H, Schellmann N, Weng A, Melzig MF et al. (2009). Saponins as tool for improved targeted tumor therapies. Curr Drug Targets 10 : 140 151.
13. Goyal A, Batra JK (2000). Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins. Biochem J 345 (Pt 2 247 254.
14. Güçlü-Ustündà O, Mazza G (2007). Saponins: properties, applications and processing. Crit Rev Food Sci Nutr 47 : 231 258.
15. Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R et al. (2002). Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjug Chem 13 : 47 58. (Pubitemid 34119634)
16. Haridas V, Higuchi M, Jayatilake GS, Bailey D, Mujoo K, Blake ME et al. (2001). Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation. Proc Natl Acad Sci USA 98 : 5821 5826. (Pubitemid 32435726)
17. Hebestreit P, Weng A, Bachran C, Fuchs H, Melzig MF (2006). Enhancement of cytotoxicity of lectins by Saponinum album. Toxicon 47 : 330 335.
18. Heisler I, Keller J, Tauber R, Sutherland M, Fuchs H (2002). A colorimetric assay for the quantitation of free adenine applied to determine the enzymatic activity of ribosome-inactivating proteins. Anal Biochem 302 : 114 122.
19. Heisler I, Keller J, Tauber R, Sutherland M, Fuchs H (2003). A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins. Int J Cancer 103 : 277 282.
20. Heisler I, Sutherland M, Bachran C, Hebestreit P, Schnitger A, Melzig MF et al. (2005). Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells. J Control Release 106 : 123 137.
21. Hu Q, Ding J, Liu S, Li P, Hu G (2003). Pharmacokinetics of magnesium glycyrrhizinate following intravenous administration of magnesium glycyrrhizinate in rats. Eur J Drug Metab Pharmacokinet 28 : 259 264.
22. Keller J, Heisler I, Tauber R, Fuchs H (2001). Development of a novel molecular adapter for the optimization of immunotoxins. J Control Release 74 : 259 261.
23. Kim YJ, Kwon HC, Ko H, Park JH, Kim HY, Yoo JH et al. (2008). Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol Pharm Bull 31 : 826 830.
24. Kwon HY, Kim EH, Kim SW, Kim SN, Park JD, Rhee DK (2008). Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation. Arch Pharm Res 31 : 171 177.
25. Liu MJ, Yue PY, Wang Z, Wong RN (2005). Methyl protodioscin induces G2/M arrest and apoptosis in K562 cells with the hyperpolarization of mitochondria. Cancer Lett 224 : 229 241.
26. Lu P, Su W, Miao ZH, Niu HR, Liu J, Hua QL (2008). Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chin J Integr Med 14 : 33 36.
27. Niu YP, Li LD, Wu LM (2008). Beta-aescin: a potent natural inhibitor of proliferation and inducer of apoptosis in human chronic myeloid leukemia K562 cells in vitro. Leuk Lymphoma 49 : 1384 1391.
28. Onda M, Beers R, Xiang L, Nagata S, Wang QC, Pastan I (2008). An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proc Natl Acad Sci USA 105 : 11311 11316.
29. Smallshaw JE, Ghetie V, Rizo J, Fulmer JR, Trahan LL, Ghetie MA et al. (2003). Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice. Nat Biotechnol 21 : 387 391.
30. Soler-Rodriguez AM, Ghetie MA, Oppenheimer-Marks N, Uhr JW, Vitetta ES (1993). Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome. Exp Cell Res 206 : 227 234.
31. Sun L, Shen J, Pang X, Lu L, Mao Y, Zeng M (2007). Phase I safety and pharmacokinetic study of magnesium isoglycyrrhizinate after single and multiple intravenous doses in Chinese healthy volunteers. J Clin Pharmacol 47 : 767 773.
32. Talpur R, Apisarnthanarax N, Ward S, Duvic M (2002). Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK). Leuk Lymphoma 43 : 121 126.
33. Wang G, Chen H, Huang M, Wang N, Zhang J, Zhang Y et al. (2006a). Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Cancer Lett 241 : 102 109.
34. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R (2006b). In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59 : 589 560.
35. Wang W, Rayburn ER, Hao M, Zhao Y, Hill DL, Zhang R et al. (2008a). Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate 68 : 809 819.
36. Wang W, Wang H, Rayburn ER, Zhao Y, Hill DL, Zhang R (2008b). 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer 98 : 792 802.
37. Weng A, Jenett-Siems K, Gorick C, Melzig MF (2008). Enhancement of cytotoxicity of ribosome-inactivating-protein type I by saponinum album is not based on stimulation of phagocytosis. J Pharm Pharmacol 60 : 925 930.
38. Weng A, Bachran D, Gorick C, Bachran C, Fuchs H, Melzig MF (2009a). A simple method for isolation of gypsophila saponins for the combined application of targeted toxins and saponins in tumor therapy. Planta Med 75 (13 1421 1422.
39. Weng A, Gorick C, Melzig MF (2009b). A brief communication: enhancement of toxicity of saporin-based toxins by gypsophila saponins - kinetic of the saponin. Exp Biol Med (Maywood) 234 : 961 966.
40. Wina E, Muetzel S, Becker K (2005). The impact of saponins or saponin-containing plant materials on ruminant production - a review. J Agric Food Chem 53 : 8093 8105.
41. Witzig TE, Flinn IW, Gordon LI, Emmanouilides C, Czuczman MS, Saleh MN et al. (2002). Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma. J Clin Oncol 20 : 3262 3269.
42. Yanamandra N, Berhow MA, Konduri S, Dinh DH, Olivero WC, Nicolson GL et al. (2003). Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells. Clin Exp Metastasis 20 : 375 383.
43. Zheng L, Zheng J, Zhao Y, Wang B, Wu L, Liang H (2006). Three anti-tumor saponins from Albizia julibrissin. Bioorg Med Chem Lett 16 : 2765 2768.